Conventional X-ray imaging has relied on attenuation contrast for more than a century, limiting the
visualization and characterization of soft tissues. Phase-contrast and dark-field X-ray imaging exploit X-
ray refraction and small-angle scattering to provide complementary information, offering improved soft-
tissue contrast and sensitivity to microstructural features beyond the detector resolution limit. Our
research focuses on the development of quantitative phase-contrast and dark-field imaging methods for
both synchrotron and laboratory-based systems, including novel Talbot-array and interferometric
approaches, spectral dark-field characterization, and quantitative phase retrieval, enabling the
extraction of material-specific information at high spatial resolution.
Recent advances span fundamental developments in quantitative synchrotron imaging and clinically
relevant applications in breast imaging. Phase-contrast mammography and breast CT have
demonstrated promising potential to improve visualization and characterization of breast lesions,
including ductal carcinoma in situ (DCIS), while nanoscale phase-contrast and dark-field techniques
offer new opportunities for quantitative tissue assessment and biomarker development. This
presentation will highlight recent methodological and translational advances, illustrating the path from
cutting-edge X-ray imaging physics toward next-generation imaging tools in biomedical applications
References
Gustschin A. et al. Optica (2021).
Heck L. et al. Journal of Medical Imaging (2020).
Hellerhoff K. et al. Medical Physics, (2025)
John D. et al. Advanced Science, (2026)
Wirtensohn S. et al. Light: Science & Applications, (2026)